Induction of potent cellular immune response in mice by hepatitis C virus NS3 protein with double-stranded RNA. (Q45404856)

14 December 2017

title

Induction of potent cellular immune response in mice by hepatitis C virus NS3 protein with double-stranded RNA. (English)

1 reference

14 December 2017

1 reference

6

Harvey J Alter

1 reference

14 December 2017

7

J Wai-Kuo Shih

1 reference

14 December 2017

Bo Jin

1

1 reference

14 December 2017

Richard Y Wang

2

1 reference

14 December 2017

Qi Qiu

3

1 reference

14 December 2017

Fuminaka Sugauchi

4

1 reference

14 December 2017

Teresa Grandinetti

5

1 reference

14 December 2017

publication date

23 April 2007

1 reference

14 December 2017

1 reference

14 December 2017

volume

122

1 reference

14 December 2017

issue

1

1 reference

14 December 2017

page(s)

15-27

1 reference

Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02607.X

The burden of hepatitis C in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02607.X

Prevention of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02607.X

Preclinical Evaluation of Two Neutralizing Human Monoclonal Antibodies against Hepatitis C Virus (HCV): a Potential Treatment To Prevent HCV Reinfection in Liver Transplant Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02607.X

Human monoclonal antibodies that react with the E2 glycoprotein of hepatitis C virus and possess neutralizing activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02607.X

Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02607.X

Sustained E2 antibody response correlates with reduced peak viremia after hepatitis C virus infection in the chimpanzee

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02607.X

When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02607.X

Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02607.X

TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02607.X

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02607.X

Toll-like receptor 3: a link between toll-like receptor, interferon and viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02607.X

Toll-like receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02607.X

Toll-like receptor 3 promotes cross-priming to virus-infected cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02607.X

Functional role of type I and type II interferons in antiviral defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02607.X

A controlled clinical trial with a specifically configured RNA drug, poly(I).poly(C12U), in chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02607.X

Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02607.X

Molecular determinants of TRIF proteolysis mediated by the hepatitis C virus NS3/4A protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02607.X

Interferon regulatory factor 3-independent double-stranded RNA-induced inhibition of hepatitis C virus replicons in human embryonic kidney 293 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02607.X

Montanide ISA 720 and 51: a new generation of water in oil emulsions as adjuvants for human vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02607.X

Modulation of cellular immune response against hepatitis C virus nonstructural protein 3 by cationic liposome encapsulated DNA immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02607.X

DNA immunization encoding the secreted nonstructural protein 3 (NS3) of hepatitis C virus and enhancing the Th1 type immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02607.X

Enhanced hepatitis C virus NS3 specific Th1 immune responses induced by co-delivery of protein antigen and CpG with cationic liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02607.X

Vigorous hepatitis C virus-specific CD4+ and CD8+ T cell responses induced by protein immunization in the presence of Montanide ISA720 plus synthetic oligodeoxynucleotides containing immunostimulatory cytosine-guanine dinucleotide motifs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02607.X

CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02607.X

Montanide ISA 720 vaccines: quality control of emulsions, stability of formulated antigens, and comparative immunogenicity of vaccine formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02607.X

Adjuvants designed for veterinary and human vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02607.X

Elevated plasma levels of IgE in Plasmodium falciparum-primed individuals reflect an increased ratio of IL-4 to interferon-gamma (IFN-gamma)-producing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02607.X

Toll-Like Receptor Ligands Modulate Dendritic Cells to Augment Cytomegalovirus- and HIV-1-Specific T Cell Responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02607.X

LPS, dsRNA and the interferon bridge to adaptive immune responses: Trif, Tram, and other TIR adaptor proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02607.X

The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02607.X

Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02607.X

Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02607.X

IFN-alpha enhances TLR3-mediated antiviral cytokine expression in human endothelial and epithelial cells by up-regulating TLR3 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02607.X

Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02607.X

Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02607.X

Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02607.X

Recombinant ovine atadenovirus induces a strong and sustained T cell response against the hepatitis C virus NS3 antigen in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02607.X

Priming with CpG-enriched plasmid and boosting with protein formulated with CpG oligodeoxynucleotides and Quil A induces strong cellular and humoral immune responses to hepatitis C virus NS3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02607.X

DNA immunization efficiently targets conserved functional domains of protease and ATPase/helicase of nonstructural 3 protein (NS3) of human hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02607.X

Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02607.X

Biochemical and immunologic properties of the nonstructural proteins of the hepatitis C virus: implications for development of antiviral agents and vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02607.X

A nuclease from animal serum which hydrolyzes double-stranded RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02607.X

Safety and immunogenicity of a three-component blood-stage malaria vaccine (MSP1, MSP2, RESA) against Plasmodium falciparum in Papua New Guinean children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02607.X

Phase I/II study of immunotherapy with T-cell peptide epitopes in patients with stage IV melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2007.02607.X

Mismatched double-stranded RNA: polyI:polyC12U

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265985

Increased activation and altered ratio of interferon-gamma: interleukin-4 secreting cells in MRL-lpr/lpr mice.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265985

Mechanism and regulation of immunoglobulin isotype switching.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265985

Therapeutic use of double-stranded RNAs in man.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265985

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265985

Adjuvant regulation of cytokine profile and antibody isotype of immune responses to Mycoplasma agalactiae in mice

29 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17451465

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Clinical, immunological, and virological effects of ampligen, a mismatched double-stranded RNA, in patients with AIDS or AIDS-related complex

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17451465

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Shaping of adaptive immune responses to soluble proteins by TLR agonists: a role for IFN-alpha/beta

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17451465

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1365-2567.2007.02607.X

1 reference

14 December 2017

0 references

1 reference